Molina Healthcare Reports Fourth Quarter and Year-End 2016 Results and Provides Fiscal Year 2017 Outlook and Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
Jefferies Maintains Hold Rating and $59 PT on Molina Healthcare (MOH) Despite Huge Guidance Miss
February 16, 2017 8:53 AM ESTJefferies analyst David Windley maintains Hold rating and $59 price target on Molina Health (NYSE: MOH), suggesting Medicaid exchange concerns produced a 40%+ guidance miss, while the company reported 2016 fourth quarter EPS figures below estimates.
Windley commented, "We stepped aside in Dec for Medicaid Expansion and Exchange (HIX)... More
Stifel Downgrades Molina Healthcare (MOH) to Hold
February 16, 2017 6:22 AM ESTStifel downgraded Molina Healthcare (NYSE: MOH) from Buy to Hold with a price target of $45.00 (from $64.00).
For an analyst ratings summary and ratings history on Molina Healthcare click here. For more ratings news on Molina Healthcare click here.
Shares of Molina Healthcare closed at $59.89 yesterday.
... MoreMolina Healthcare (MOH) Reports Q4 Loss Per Share of $1.54
February 15, 2017 4:18 PM ESTMolina Healthcare (NYSE: MOH) reported Q4 EPS of ($1.54), may not compare to the analyst estimate of $0.75. Revenue for the quarter came in at $4.46 billion versus the consensus estimate of $4.55 billion.
2017 guidance of $1.72 net income per diluted share and $2.09 adjusted net income... More